Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEM: Sirolimus vs Everolimus vs Mycophenolate in Kidney Transplant
NCT03468478Phase 4Completed
- Sponsor
- Hospital do Rim e Hipertensão
- Start
- Jun 2017
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sirolimus, everolimus in kidney transplant rejection, sponsored by Hospital do Rim e Hipertensão. Started Jun 2017; status: completed.
02
Drugs
sirolimuseverolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT03468478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03468478.